|
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial |
|
|
|
Title: |
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial |
Author: |
Weishaupt, Carsten Strölin, Anke Kahle, Birgit Kreuter, Alexander Schneider, Stefan W Gerss, Joachim Eveslage, Maria Drabik, Attyla Goerge, Tobias |
Appeared in: |
The Lancet. Haematology |
Paging: |
Volume 3 (2016) nr. 2 pages nvt p. |
Year: |
2016 |
Contents: |
|
Publisher: |
Elsevier Ltd |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|